17 min listen
Unavailable
ratings:
Length:
14 minutes
Released:
Jun 29, 2021
Format:
Podcast episode
Description
Before Covid, dementia was the biggest killer in the UK and Alzheimer’s disease is the most common type. A controversial new drug for Alzheimer’s, aducanumab, is the first in nearly 20 years to be approved in the US, which will trigger pressure to make it available worldwide. The Guardian’s health editor, Sarah Bosley, talks Shivani Dave through the mixed evidence of its efficacy. Help support our independent journalism at theguardian.com/sciencepod
Released:
Jun 29, 2021
Format:
Podcast episode
Titles in the series (100)
From the archive: the secret, sonic lives of narwhals: From 2020: Nicola Davis speaks to Evgeny Podolskiy about capturing the sonic world of narwhals by Science Weekly